Literature DB >> 28104909

Selective neuronal vulnerability in Parkinson disease.

D James Surmeier1, José A Obeso2,3, Glenda M Halliday4,5.   

Abstract

Intracellular α-synuclein (α-syn)-rich protein aggregates called Lewy pathology (LP) and neuronal death are commonly found in the brains of patients with clinical Parkinson disease (cPD). It is widely believed that LP appears early in the disease and spreads in synaptically coupled brain networks, driving neuronal dysfunction and death. However, post-mortem analysis of human brains and connectome-mapping studies show that the pattern of LP in cPD is not consistent with this simple model, arguing that, if LP propagates in cPD, it must be gated by cell- or region-autonomous mechanisms. Moreover, the correlation between LP and neuronal death is weak. In this Review, we briefly discuss the evidence for and against the spreading LP model, as well as evidence that cell-autonomous factors govern both α-syn pathology and neuronal death.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28104909      PMCID: PMC5564322          DOI: 10.1038/nrn.2016.178

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  172 in total

1.  The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease.

Authors:  E Ilijic; J N Guzman; D J Surmeier
Journal:  Neurobiol Dis       Date:  2011-04-16       Impact factor: 5.996

Review 2.  Autophagy gone awry in neurodegenerative diseases.

Authors:  Esther Wong; Ana Maria Cuervo
Journal:  Nat Neurosci       Date:  2010-07       Impact factor: 24.884

Review 3.  Hypothalamic regulation of sleep and circadian rhythms.

Authors:  Clifford B Saper; Thomas E Scammell; Jun Lu
Journal:  Nature       Date:  2005-10-27       Impact factor: 49.962

Review 4.  Genes associated with Parkinson's disease: regulation of autophagy and beyond.

Authors:  Alexandra Beilina; Mark R Cookson
Journal:  J Neurochem       Date:  2015-09-03       Impact factor: 5.372

5.  Midbrain neuropathology in idiopathic Parkinson's disease and diffuse Lewy body disease.

Authors:  G M Halliday; D A McRitchie; H Cartwright; R Pamphlett; M A Hely; J G Morris
Journal:  J Clin Neurosci       Date:  1996-01       Impact factor: 1.961

6.  Use of calcium channel blockers and Parkinson's disease.

Authors:  Björn Pasternak; Henrik Svanström; Nete M Nielsen; Lars Fugger; Mads Melbye; Anders Hviid
Journal:  Am J Epidemiol       Date:  2012-03-01       Impact factor: 4.897

7.  Caudo-rostral brain spreading of α-synuclein through vagal connections.

Authors:  Ayse Ulusoy; Raffaella Rusconi; Blanca I Pérez-Revuelta; Ruth E Musgrove; Michael Helwig; Bettina Winzen-Reichert; Donato A Di Monte
Journal:  EMBO Mol Med       Date:  2013-05-23       Impact factor: 12.137

Review 8.  Interactions between calcium and alpha-synuclein in neurodegeneration.

Authors:  Alex Rcom-H'cheo-Gauthier; Jacob Goodwin; Dean L Pountney
Journal:  Biomolecules       Date:  2014-08-14

Review 9.  Neuronal calcium signaling: function and dysfunction.

Authors:  Marisa Brini; Tito Calì; Denis Ottolini; Ernesto Carafoli
Journal:  Cell Mol Life Sci       Date:  2014-01-19       Impact factor: 9.261

10.  alpha-Synuclein and neuronal cell death.

Authors:  Mark R Cookson
Journal:  Mol Neurodegener       Date:  2009-02-04       Impact factor: 14.195

View more
  272 in total

1.  Synj1 haploinsufficiency causes dopamine neuron vulnerability and alpha-synuclein accumulation in mice.

Authors:  Ping-Yue Pan; Patricia Sheehan; Qian Wang; Xinyu Zhu; Yuanxi Zhang; Insup Choi; Xianting Li; Jacqueline Saenz; Justin Zhu; Jing Wang; Farida El Gaamouch; Li Zhu; Dongming Cai; Zhenyu Yue
Journal:  Hum Mol Genet       Date:  2020-08-11       Impact factor: 6.150

2.  Glial α-synuclein promotes neurodegeneration characterized by a distinct transcriptional program in vivo.

Authors:  Abby L Olsen; Mel B Feany
Journal:  Glia       Date:  2019-07-03       Impact factor: 7.452

3.  Mitochondrial clearance and maturation of autophagosomes are compromised in LRRK2 G2019S familial Parkinson's disease patient fibroblasts.

Authors:  Joanna A Korecka; Ria Thomas; Dan P Christensen; Anthony J Hinrich; Eliza J Ferrari; Simon A Levy; Michelle L Hastings; Penelope J Hallett; Ole Isacson
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

4.  Systemic isradipine treatment diminishes calcium-dependent mitochondrial oxidant stress.

Authors:  Jaime N Guzman; Ema Ilijic; Ben Yang; Javier Sanchez-Padilla; David Wokosin; Dan Galtieri; Jyothisri Kondapalli; Paul T Schumacker; D James Surmeier
Journal:  J Clin Invest       Date:  2018-04-30       Impact factor: 14.808

5.  Evidence for Compartmentalized Axonal Mitochondrial Biogenesis: Mitochondrial DNA Replication Increases in Distal Axons As an Early Response to Parkinson's Disease-Relevant Stress.

Authors:  Victor S Van Laar; Beth Arnold; Evan H Howlett; Michael J Calderon; Claudette M St Croix; J Timothy Greenamyre; Laurie H Sanders; Sarah B Berman
Journal:  J Neurosci       Date:  2018-07-20       Impact factor: 6.167

Review 6.  Microglia and astrocyte dysfunction in parkinson's disease.

Authors:  Tae-In Kam; Jared T Hinkle; Ted M Dawson; Valina L Dawson
Journal:  Neurobiol Dis       Date:  2020-07-28       Impact factor: 5.996

Review 7.  Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.

Authors:  Gunasingh J Masilamoni; Yoland Smith
Journal:  J Neural Transm (Vienna)       Date:  2017-08-31       Impact factor: 3.575

Review 8.  Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease.

Authors:  Fanni F Geibl; Martin T Henrich; Wolfgang H Oertel
Journal:  J Neural Transm (Vienna)       Date:  2019-01-14       Impact factor: 3.575

Review 9.  Assessing drug response in engineered brain microenvironments.

Authors:  Kinsley M Tate; Jennifer M Munson
Journal:  Brain Res Bull       Date:  2019-05-01       Impact factor: 4.077

10.  E46K α-synuclein pathological mutation causes cell-autonomous toxicity without altering protein turnover or aggregation.

Authors:  Ignacio Íñigo-Marco; Miguel Valencia; Laura Larrea; Ricardo Bugallo; Mikel Martínez-Goikoetxea; Iker Zuriguel; Montserrat Arrasate
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.